The global home infusion therapy market size is likely to USD 86.89 billion by the end of 2027 owing to the increasing adoption of home medical services worldwide. In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route. According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Industry Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration) Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027, ”the value of this market was USD 27.25 billion in 2019 and is expected to grow at a CAGR of 2.2% between 2020 and 2027.

visit: https://www.fortunebusinessinsights.com/home-infusion-therapy-market-102989

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Lockdowns Amid COVID-19 Pandemic to Bode Well for the Market

The increasing prevalence of the geriatric population and their vulnerability towards chronic diseases such as cancer, diabetes, and cardiac issues among others stands as major home infusion therapy market devices. In addition to this, the increasing cases of hospital-acquired infections are also propelling people This, coupled with cost-efficient home treatment faster recovery at home than hospital are likely to bode well for the market.

Drugs Segment to Hold Dominance Owing to Increasing Incidences of Cancer

Based on segmentation by product, the drugs segment earned the highest home infusion therapy market share on account of the increasing number of immune diseases worldwide and the rising prevalence of cancer. Besides this, the devices segment earned a 6.6% share and is likely to witness significant growth in the coming years on account of increasing technological advancements in the delivery of home medication system for various purposes.